Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/4/2025

Management of Metabolic Abnormalities and Elevated PSA in Older Men

Prostate Cancer Evaluation

  • The American Urological Association recommends that a PSA of 19 ng/mL is significantly elevated and requires immediate urologic referral for prostate biopsy to rule out prostate cancer before any other interventions 1, 3
  • The American Urological Association suggests that digital rectal examination (DRE) should be performed to assess for prostate abnormalities that might suggest locally advanced cancer 3
  • The American College of Physicians recommends that testosterone replacement should not be initiated until prostate cancer has been ruled out, as there is concern that testosterone therapy could stimulate growth of occult prostate cancer 2, 4
  • If prostate biopsy is negative, the American Urological Association suggests that testosterone therapy could be considered with close monitoring of PSA 1

Testosterone Deficiency Management

  • The Endocrine Society recommends that the patient has severe hypogonadism (testosterone 30 ng/dL), which may contribute to his metabolic abnormalities 5, 6
  • Before initiating testosterone therapy (if prostate cancer is ruled out), the American Urological Association recommends measuring morning free testosterone to confirm diagnosis 6, 7
  • The Endocrine Society suggests checking luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to determine primary vs. secondary hypogonadism 8, 7
  • The American Urological Association recommends measuring hemoglobin/hematocrit (baseline Hct >50% warrants investigation before starting therapy) 1, 7

Hyperglycemia Management

  • The American Diabetes Association recommends that fasting glucose of 184 mg/dL and HbA1c of 6.8% indicate diabetes requiring treatment 9, 5
  • The American Diabetes Association suggests that low testosterone may be contributing to insulin resistance and hyperglycemia 6
  • The American Diabetes Association recommends initial management approach including lifestyle modifications and considering metformin as first-line pharmacotherapy if not contraindicated 9, 5

Important Considerations and Pitfalls

  • The American Heart Association recommends avoiding testosterone therapy if severe renal impairment is present; assess renal function before initiating treatment 1, 7
  • The American Diabetes Association suggests that testosterone replacement in older men with hypogonadism has been associated with increased coronary artery disease risk and higher A1C levels, requiring careful risk-benefit assessment 5

Monitoring Plan

  • The American Urological Association recommends monitoring PSA and hematocrit at 3, 6, and 12 months, then annually if prostate cancer is ruled out and testosterone therapy initiated 2
  • The American Diabetes Association recommends monitoring glucose and HbA1c every 3 months until stable, then every 6 months 9, 5